disulfiram has been researched along with transforming growth factor beta in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, C; Han, D; Li, Q; Wu, G; Xiao, Y; Zhang, L; Zhang, T; Zhu, F | 1 |
| Chung, RT; Goto, K; Kato, N | 1 |
| Li, TY; Li, Y; Liu, S; Wang, LH; Wang, YT; Wu, CF; Yang, JY; Yuan, XZ; Zhang, HT; Zhou, WL | 1 |
| Cheng, SJ; Feng, L; He, JY; Mao, SS; Pang, Y; Sun, W; Yao, R; Zhang, KT; Zhou, ZZ | 1 |
| Cai, Y; Duan, S; Jiang, H; Li, M; Liu, J; Lou, X; Qian, F; Sun, L; Tang, H; Yang, X; Zhao, W; Zhao, Y | 1 |
5 other study(ies) available for disulfiram and transforming growth factor beta
| Article | Year |
|---|---|
Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
Topics: Alcohol Deterrents; Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Disulfiram; Electrophoretic Mobility Shift Assay; Epithelial-Mesenchymal Transition; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; NF-kappa B; Snail Family Transcription Factors; Transcription Factors; Transforming Growth Factor beta; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.
Topics: Alcohol Deterrents; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Disulfiram; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Kinetics; Liver Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Signal Transduction; Transforming Growth Factor beta | 2016 |
Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Copper; Disulfiram; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Liver Neoplasms; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Phenotype; Signal Transduction; Smad4 Protein; Transforming Growth Factor beta; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2018 |
TGF-β induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing.
Topics: Biomarkers, Tumor; Cell Shape; Disulfiram; Epithelial-Mesenchymal Transition; Female; HeLa Cells; Humans; Printing, Three-Dimensional; Spheroids, Cellular; Transforming Growth Factor beta; Uterine Cervical Neoplasms | 2018 |
Tetraethylthiuram disulphide alleviates pulmonary fibrosis through modulating transforming growth factor-β signalling.
Topics: Actins; Alcohol Deterrents; Animals; Bleomycin; Collagen Type I, alpha 1 Chain; Disulfiram; Fibronectins; HEK293 Cells; Humans; Lung; Male; Mice; Mice, Inbred C57BL; NIH 3T3 Cells; Pulmonary Fibrosis; Signal Transduction; Transforming Growth Factor beta | 2021 |